Deferiprone comment watch save
BreastfeedingGeriatricPediatric

  • TRADE NAME: Ferriprox (ApoPharma)
  • INDICATIONS: Treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate
  • CLASS: Chelator, iron
  • HALF-LIFE: 1.9 hours
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    Antacids containing iron, aluminum, zinc, Diclofenac, Mineral supplements, Probenecid

AGRANULOCYTOSIS / NEUTROPENIA

See full prescribing information for complete boxed warning.

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top